INS and type 2 diabetes mellitus: IDegLira (brand name Xultophy) is a fixed ratio innovation of basal insulin [Degludec ([IDeg)] and GLP-1 RA analog [Liraglutide (Lira)] and is administered as a once-daily subcutaneous injection for the treatment of T2D.